Leo Wealth LLC’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4M Buy
65,938
+13,804
+26% +$805K 0.29% 74
2025
Q4
$2.81M Buy
52,134
+14,033
+37% +$675K 0.2% 86
2025
Q3
$1.72M Sell
38,101
-7,131
-16% -$333K 0.22% 84
2025
Q2
$2.09M Buy
45,232
+38,286
+551% +$1.88M 0.16% 112
2025
Q1
$424K Sell
6,946
-8,019
-54% -$467K 0.06% 186
2024
Q4
$846K Buy
14,965
+5,085
+51% +$284K 0.08% 171
2024
Q3
$511K Sell
9,880
-861
-8% -$40.4K 0.05% 222
2024
Q2
$445K Sell
10,741
-32,987
-75% -$1.48M 0.05% 232
2024
Q1
$2.36M Sell
43,728
-2,841
-6% -$145K 0.24% 72
2023
Q4
$2.41M Buy
+46,569
New +$2.44M 0.25% 71

Other funds holding BMY

Leo Wealth LLC's BMY Position: Q1 2026 in Review

Leo Wealth LLC increased its Bristol-Myers Squibb (BMY) stake by 26% in Q1 2026, buying an estimated $805K and bringing the position to 65,938 shares worth $4M. The position accounts for 0.29% of the portfolio, ranked #74.

Leo Wealth LLC first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Leo Wealth LLC held 65,938 shares of Bristol-Myers Squibb worth $4M as of Q1 2026.
  • Leo Wealth LLC bought 13,804 Bristol-Myers Squibb shares in Q1 2026, an estimated $805K.
  • Bristol-Myers Squibb made up 0.29% of Leo Wealth LLC's portfolio in Q1 2026, its #74 holding.
  • Leo Wealth LLC first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Leo Wealth LLC's 13F filing for Q1 2026, filed 5 May 2026.